Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.67)
# 824
Out of 5,065 analysts
368
Total ratings
53.1%
Success rate
16.5%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: MEDCL MedinCell S.A. | Downgraded: Hold | €36.60 → €31.00 | €26.30 | +17.87% | 34 | Oct 14, 2026 | |
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | 1,855p | +35.63% | 2 | May 26, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 130.00 | CHF 51.40 | +152.92% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 80.00 | CHF 76.58 | +4.47% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Reiterated: Buy | €5.00 | €6.00 | -16.67% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Reiterated: Buy | €8.20 | €2.08 | +294.23% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Reiterated: Buy | CHF 4.50 | CHF 4.18 | +7.60% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Reiterated: Buy | CHF 66.00 → CHF 73.00 | CHF 48.65 | +50.05% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €85.00 | €71.01 | +19.70% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €33.00 | €19.88 | +66.00% | 51 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €20.30 | €12.92 | +57.12% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €5.00 | €2.86 | +74.83% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €15.00 | €5.96 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €390.00 | €337.00 | n/a | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €0.80 → €0.64 | €0.04 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $89 → $46 | $29.79 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €79.00 → €41.00 | €26.46 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $383 → $420 | $825.61 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 57.00 | CHF 67.60 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €1.00 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | €2.42 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €0.60 → €0.40 | €0.42 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €2.70 | €0.30 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 | €2.27 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.00 | €77.95 | n/a | 1 | Dec 21, 2022 |
MedinCell S.A.
Oct 14, 2026
Downgraded: Hold
Price Target: €36.60 → €31.00
Current: €26.30
Upside: +17.87%
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: 1,855p
Upside: +35.63%
Cosmo N.V.
May 11, 2026
Reiterated: Buy
Price Target: CHF 130.00
Current: CHF 51.40
Upside: +152.92%
Sandoz Group AG
May 11, 2026
Reiterated: Buy
Price Target: CHF 80.00
Current: CHF 76.58
Upside: +4.47%
Carvolix SA
May 4, 2026
Reiterated: Buy
Price Target: €5.00
Current: €6.00
Upside: -16.67%
OSE Immunotherapeutics SA
Apr 30, 2026
Reiterated: Buy
Price Target: €8.20
Current: €2.08
Upside: +294.23%
Idorsia Ltd
Apr 28, 2026
Reiterated: Buy
Price Target: CHF 4.50
Current: CHF 4.18
Upside: +7.60%
BB Biotech AG
Apr 24, 2026
Reiterated: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: CHF 48.65
Upside: +50.05%
Sanofi
Apr 23, 2026
Reiterated: Hold
Price Target: €85.00
Current: €71.01
Upside: +19.70%
Formycon AG
Apr 22, 2026
Reiterated: Buy
Price Target: €33.00
Current: €19.88
Upside: +66.00%
Apr 1, 2026
Reiterated: Buy
Price Target: €20.30
Current: €12.92
Upside: +57.12%
Feb 25, 2026
Reiterated: Buy
Price Target: €5.00
Current: €2.86
Upside: +74.83%
Sep 25, 2025
Reiterated: Hold
Price Target: €15.00
Current: €5.96
Upside: n/a
Jul 17, 2025
Reiterated: Hold
Price Target: €390.00
Current: €337.00
Upside: n/a
May 6, 2024
Reiterated: Sell
Price Target: €0.80 → €0.64
Current: €0.04
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $89 → $46
Current: $29.79
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: €79.00 → €41.00
Current: €26.46
Upside: n/a
Feb 20, 2024
Reiterated: Hold
Price Target: $383 → $420
Current: $825.61
Upside: n/a
Nov 20, 2023
Reiterated: Buy
Price Target: CHF 57.00
Current: CHF 67.60
Upside: n/a
Sep 7, 2023
Reiterated: Buy
Price Target: €16.00
Current: €1.00
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: €2.42
Upside: n/a
May 3, 2023
Reiterated: Buy
Price Target: €0.60 → €0.40
Current: €0.42
Upside: n/a
Apr 28, 2023
Reiterated: Buy
Price Target: €2.70
Current: €0.30
Upside: n/a
Dec 29, 2022
Reiterated: Buy
Price Target: €12.00
Current: €2.27
Upside: n/a
Dec 21, 2022
Reiterated: Buy
Price Target: €16.00
Current: €77.95
Upside: n/a